207 related articles for article (PubMed ID: 31808044)
1. Definition and diagnosis of aggressive pituitary tumors.
Kasuki L; Raverot G
Rev Endocr Metab Disord; 2020 Jun; 21(2):203-208. PubMed ID: 31808044
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of aggressive pituitary tumors (and its challenges).
Dekkers OM; Karavitaki N; Pereira AM
Rev Endocr Metab Disord; 2020 Jun; 21(2):209-212. PubMed ID: 32361816
[TBL] [Abstract][Full Text] [Related]
3. Aggressive Pituitary Adenomas and Carcinomas.
Ilie MD; Jouanneau E; Raverot G
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):505-515. PubMed ID: 32741485
[TBL] [Abstract][Full Text] [Related]
4. Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions.
Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C
Rev Endocr Metab Disord; 2020 Jun; 21(2):243-251. PubMed ID: 32504268
[TBL] [Abstract][Full Text] [Related]
5. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
6. Early recognition of aggressive pituitary adenomas: a single-centre experience.
Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas.
Buchfelder M; Schlaffer SM
Rev Endocr Metab Disord; 2020 Jun; 21(2):253-261. PubMed ID: 32500483
[TBL] [Abstract][Full Text] [Related]
8. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
9. Aggressive pituitary tumors in the young and elderly.
Tatsi C; Stratakis CA
Rev Endocr Metab Disord; 2020 Jun; 21(2):213-223. PubMed ID: 31912365
[TBL] [Abstract][Full Text] [Related]
10. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
11. Invasive, atypical and aggressive pituitary adenomas and carcinomas.
Sav A; Rotondo F; Syro LV; Di Ieva A; Cusimano MD; Kovacs K
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):99-104. PubMed ID: 25732646
[TBL] [Abstract][Full Text] [Related]
12. Targeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomas.
Petersenn S; Heaney AP
Rev Endocr Metab Disord; 2020 Jun; 21(2):277-286. PubMed ID: 32415583
[TBL] [Abstract][Full Text] [Related]
13. Refractory pituitary adenoma: a novel classification for pituitary tumors.
Dai C; Feng M; Liu X; Ma S; Sun B; Bao X; Yao Y; Deng K; Wang Y; Xing B; Lian W; Zhong D; Ma W; Wang R
Oncotarget; 2016 Dec; 7(50):83657-83668. PubMed ID: 27845901
[TBL] [Abstract][Full Text] [Related]
14. Invasive pituitary adenomas: significance of proliferation parameters.
Amar AP; Hinton DR; Krieger MD; Weiss MH
Pituitary; 1999 Aug; 2(2):117-22. PubMed ID: 11081161
[TBL] [Abstract][Full Text] [Related]
15. [Aggressive pituitary adenoma and pituitary carcinoma].
Tóth M
Orv Hetil; 2023 Jul; 164(30):1167-1175. PubMed ID: 37516994
[TBL] [Abstract][Full Text] [Related]
16. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment for invasive pituitary adenomas.
Hornyak M; Couldwell WT
Postgrad Med; 2009 Mar; 121(2):168-76. PubMed ID: 19332975
[TBL] [Abstract][Full Text] [Related]
18. Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas.
Zaidi HA; Cote DJ; Dunn IF; Laws ER
J Clin Neurosci; 2016 Dec; 34():246-251. PubMed ID: 27765563
[TBL] [Abstract][Full Text] [Related]
19. Carcinomas of the pituitary: definition and review of the literature.
Lübke D; Saeger W
Gen Diagn Pathol; 1995 Oct; 141(2):81-92. PubMed ID: 8548598
[TBL] [Abstract][Full Text] [Related]
20. Non-functioning pituitary adenomas: growth and aggressiveness.
Øystese KA; Evang JA; Bollerslev J
Endocrine; 2016 Jul; 53(1):28-34. PubMed ID: 27066792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
